Form 4: Stoke Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Barry Ticho, CHIEF MEDICAL OFFICER of Stoke Therapeutics, Inc., sold 1,051 shares of common stock on October 1, 2026 for $26.16 per share.
Summary
- Open-market sale: disposed of 1,051 Common Stock at $26.16 ($27,494) on October 1, 2026; holds 19,059 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $27,494 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Barry Ticho — Officer (CHIEF MEDICAL OFFICER)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 1,051 | $26 | $27.5K | 19,059 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (1,051 shares) |
Keywords
insider transaction, Form 4, STOK, Stoke Therapeutics, Inc., bearish, Barry Ticho
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.